Refine
Has Fulltext
- yes (42)
Is part of the Bibliography
- yes (42)
Year of publication
- 2011 (42) (remove)
Document Type
- Journal article (42) (remove)
Language
- English (42)
Keywords
- Biology (2)
- DNA (2)
- Fusion proteins (2)
- PALM (2)
- dSTORM (2)
- fluorescent proteins (2)
- photoswitchable organic fluorophores (2)
- super-resolution (2)
- 26S RDNA Data (1)
- AFLP (1)
- Activation (1)
- Adenocarcinomas (1)
- African Trypanosomes (1)
- Allelic loss (1)
- Amazonian forest (1)
- Ameisen (1)
- Amplification (1)
- Ant-following birds (1)
- Antibody (1)
- Apoptosis (1)
- Assemblages (1)
- B chromosomes (1)
- Bacillus-subtilis (1)
- Barcodes (1)
- Behavior (1)
- Biene (1)
- Biological identifications (1)
- Biologie (1)
- Blattschneiderameisen (1)
- Blood-brain-barrier (1)
- Bone morphogenetic protein-2 (1)
- Brownsche Bewegung (1)
- Brucei (1)
- CYR61 (1)
- Cancer (1)
- Cataglyphis-fortis (1)
- Cell Motility (1)
- Cell surface (1)
- Cell-line (1)
- Central complex (1)
- Chemotaxis (1)
- Children (1)
- Chlamydia pneumoniae (1)
- Chlamydiales (1)
- Coleoptera (1)
- Colonial volvocales chlorophyta (1)
- Components (1)
- Conservation (1)
- CrossQuery (1)
- Cytologie (1)
- DNA barcodes (1)
- DNA recombination (1)
- Dasycladales chlorophyta (1)
- Desert ant navigation (1)
- Dorylinae (1)
- Drosophila Antennal Lobe (1)
- Edema formation (1)
- Embryo (1)
- Experimental intracerebral hemorrhage (1)
- Factor sigma(B) (1)
- Fische (1)
- Flagellum (1)
- Fluorescence microscopy (1)
- Formicidae (1)
- Functional diversity (1)
- GAG (1)
- Gene-expression (1)
- Genetik (1)
- Geruch (1)
- Gram-positive bacteria (1)
- Habitat fragmentation (1)
- Heparan-sulfate (1)
- Honey-bees (1)
- Human lung-cancer (1)
- Human-immunodeficiency-virus (1)
- IN-VIVO (1)
- In-vivo (1)
- Induced senescence (1)
- K-RAS (1)
- Kinase pathway (1)
- Krebs (1)
- LINC complex (1)
- Land plants (1)
- Land-use change (1)
- Landschaft (1)
- Landwirtschaft (1)
- Limit (1)
- Listeria monocytogenes (1)
- Live cells (1)
- Living cells (1)
- Logged forests (1)
- Lov domain (1)
- Lung-cancer (1)
- Madagascar (1)
- Magnetic-resonance microscopy (1)
- Maus (1)
- Mechanisms (1)
- Medizin (1)
- Melophorus-bagoti (1)
- Microarray data (1)
- Middle cerebral-artery (1)
- Model (1)
- Molecular systematics (1)
- Molecules (1)
- Monte-Carlo-Simulation (1)
- Motion (1)
- Mouse-brain (1)
- Movement (1)
- Mushroom bodies (1)
- Myofibroblast differentiation (1)
- N-Myc (1)
- NTP-binding-properties (1)
- Neuro-blastoma (1)
- Non-phototrophic bacteria (1)
- Nuclear RDNA (1)
- P53 (1)
- Parataxonomy (1)
- Partially parallel acquisitions (1)
- Path-integraton (1)
- Patterns (1)
- Photoactivated localization microscopy (1)
- Plantation forests (1)
- Plasma-membrane (1)
- Prfa-mediated virulence (1)
- Profile distances (1)
- Proliferation (1)
- Prunus-africana (1)
- RBCL Gene-sequences (1)
- Rain-forest (1)
- Random-Walk (1)
- Rat spinal-cord (1)
- Real-time (1)
- Receptor (1)
- Receptor ytva (1)
- Recurrent neural-networks (1)
- SUN domain protein (1)
- Secondary structure (1)
- Seed dispersal (1)
- Serum autoantibodies (1)
- Sigma(B)-dependent stress-response (1)
- Smooth-muscle-cells (1)
- Species richness (1)
- Sprouting angiogenesis (1)
- Squalius alburnoides (1)
- Stachellose Biene (1)
- Stimulated-emission (1)
- Sun1 (1)
- Super-Resolution Microscopy (1)
- Suppressors EXT1 (1)
- Switch (1)
- Systematic search (1)
- TGF-beta (1)
- TYPE-1 (1)
- Taxonomy (1)
- Therapy (1)
- Time (1)
- Trypanosoma brucei (1)
- Trypanosome (1)
- VASP (1)
- VSG (1)
- Vasodilatator-stimuliertes Phosphoprotein (1)
- White-matter (1)
- Wilms tumor (1)
- Zoologie (1)
- ant (1)
- antennal lobe (1)
- antigen processing and recognition (1)
- asexual reproduction (1)
- autofluorescence (1)
- cameleon (1)
- comparative genomics (1)
- cyclic nucleotide signaling (1)
- diet (1)
- drosophila melanogaster (1)
- gel electrophoresis (1)
- gene flow (1)
- genetically modified crops (1)
- genetically modified plants (1)
- genomic databases (1)
- glomerulus (1)
- gynogenesis (1)
- homologous recombination (1)
- honey bees (1)
- honeybee (1)
- hybridomas (1)
- immunohistochemistry techniques (1)
- immunoprecipitation (1)
- insect pests (1)
- insects (1)
- interspecific comparison (1)
- introgression (1)
- isoform (1)
- larvae (1)
- macroglomerulus (1)
- maize (1)
- map (1)
- melanogaster (1)
- meningococcal disease (1)
- microdissection (1)
- microsatellites (1)
- mouse (1)
- mtDNA (1)
- mushroom body (1)
- neisseria meningitidis (1)
- nephroblastoma (1)
- neurons (1)
- neuropil (1)
- nuclear envelope (1)
- olfaction (1)
- olfactory glomeruli (1)
- olfactory information (1)
- organization (1)
- paternal introgression (1)
- plasticity (1)
- pollen (1)
- population genetics (1)
- primary tumor cell culture (1)
- recombinant proteins (1)
- retinoic acid (1)
- reveals (1)
- silico model (1)
- silver staining (1)
- spatial representation (1)
- telomeres (1)
- tumor model (1)
- unicellular cyanobacteria (1)
- variability analysis (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (42) (remove)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 226852 (1)
Background: Hemostasis is a critical and active function of the blood mediated by platelets. Therefore, the prevention of pathological platelet aggregation is of great importance as well as of pharmaceutical and medical interest. Endogenous platelet inhibition is predominantly based on cyclic nucleotides (cAMP, cGMP) elevation and subsequent cyclic nucleotide-dependent protein kinase (PKA, PKG) activation. In turn, platelet phosphodiesterases (PDEs) and protein phosphatases counterbalance their activity. This main inhibitory pathway in human platelets is crucial for countervailing unwanted platelet activation. Consequently, the regulators of cyclic nucleotide signaling are of particular interest to pharmacology and therapeutics of atherothrombosis. Modeling of pharmacodynamics allows understanding this intricate signaling and supports the precise description of these pivotal targets for pharmacological modulation. Results: We modeled dynamically concentration-dependent responses of pathway effectors (inhibitors, activators, drug combinations) to cyclic nucleotide signaling as well as to downstream signaling events and verified resulting model predictions by experimental data. Experiments with various cAMP affecting compounds including antiplatelet drugs and their combinations revealed a high fidelity, fine-tuned cAMP signaling in platelets without crosstalk to the cGMP pathway. The model and the data provide evidence for two independent feedback loops: PKA, which is activated by elevated cAMP levels in the platelet, subsequently inhibits adenylyl cyclase (AC) but as well activates PDE3. By multi-experiment fitting, we established a comprehensive dynamic model with one predictive, optimized and validated set of parameters. Different pharmacological conditions (inhibition, activation, drug combinations, permanent and transient perturbations) are successfully tested and simulated, including statistical validation and sensitivity analysis. Downstream cyclic nucleotide signaling events target different phosphorylation sites for cAMP- and cGMP-dependent protein kinases (PKA, PKG) in the vasodilator-stimulated phosphoprotein (VASP). VASP phosphorylation as well as cAMP levels resulting from different drug strengths and combined stimulants were quantitatively modeled. These predictions were again experimentally validated. High sensitivity of the signaling pathway at low concentrations is involved in a fine-tuned balance as well as stable activation of this inhibitory cyclic nucleotide pathway. Conclusions: On the basis of experimental data, literature mining and database screening we established a dynamic in silico model of cyclic nucleotide signaling and probed its signaling sensitivity. Thoroughly validated, it successfully predicts drug combination effects on platelet function, including synergism, antagonism and regulatory loops.
Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro
(2011)
Background: Wilms tumor (WT) is one of the most common malignancies in childhood. With current therapy protocols up to 90% of patients can be cured, but there is still a need to improve therapy for patients with aggressive WT and to reduce treatment intensity where possible. Prior data suggested a deregulation of the retinoic acid (RA) signaling pathway in high-risk WT, but its mode of action remained unclear. Results: The association of retinoid signaling and clinical parameters could be validated in a large independent tumor set, but its relevance in primary nephrectomy tumors from very young children may be different. Reduced RA pathway activity and MYCN overexpression were found in high risk tumors as opposed to tumors with low/ intermediate risk, suggesting a beneficial impact of RA especially on advanced WT. To search for possible modes of action of retinoids as novel therapeutic options, primary tumor cell cultures were treated in vitro with all-trans-RA (ATRA), 9cis-RA, fenretinide and combinations of retinoids and a histone deacetylase (HDAC) inhibitor. Genes deregulated in high risk tumors showed opposite changes upon treatment suggesting a positive effect of retinoids. 6/7 primary cultures tested reduced proliferation, irrespective of prior RA signaling levels. The only variant culture was derived from mesoblastic nephroma, a distinct childhood kidney neoplasm. Retinoid/HDAC inhibitor combinations provided no synergistic effect. ATRA and 9cis-RA induced morphological changes suggestive of differentiation, while fenretinide induced apoptosis in several cultures tested. Microarray analysis of ATRA treated WT cells revealed differential expression of many genes involved in extracellular matrix formation and osteogenic, neuronal or muscle differentiation. The effects documented appear to be reversible upon drug withdrawal, however. Conclusions: Altered retinoic acid signaling has been validated especially in high risk Wilms tumors. In vitro testing of primary tumor cultures provided clear evidence of a potential utility of retinoids in Wilms tumor treatment based on the analysis of gene expression, proliferation, differentiation and apoptosis.